Objective: Poor sleep quality has been linked to inflammatory processes and worse disease outcomes in the context of many chronic illnesses, but less is known in conditions such as chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). This study examines the relationships between sleep quality, pro-inflammatory cytokines, and CFS/ME symptoms. Methods: Sixty women diagnosed with CFS/ME were assessed using the Pittsburgh Sleep Quality Index (PSQI), Fatigue Symptom Inventory (FSI) and Center for Disease Control and Prevention (CDC)-based CFS/ME symptom questionnaires. Circulating plasma pro-inflammatory cytokine levels were measured by ELISA. Multiple regression analyses examined associations between sleep, cytokines and symptoms, controlling for age, education, and body mass index. Results: Poor sleep quality (PSQI global score) was associated with greater pro-inflammatory cytokine levels: interleukin-1β (IL-1β) (β = 0.258, p = 0.043), IL-6 (β = 0.281, p = 0.033), and tumor necrosis factor-alpha (TNF-α) (β = 0.263, p = 0.044). Worse sleep quality related to greater fatigue severity (β = 0.395, p = 0.003) and fatigue-related interference with daily activities (β = 0.464, p b 0.001), and more severe and frequent CDCdefined core CFS/ME symptoms (β = 0.499, p b 0.001, and β = 0.556, p b 0.001, respectively). Conclusions: Results underscore the importance of managing sleep-related difficulties in this patient population. Further research is needed to identify the etiology of sleep disruptions in CFS/ME and mechanistic factors linking sleep quality to symptom severity and inflammatory processes.
Introduction
Poor sleep quality has been implicated in worse health outcomes in various clinical populations and also contributes to diminished physical and psychological well-being in otherwise healthy individuals (Lorton et al., 2006; Okun et al., 2013) . In a variety of clinical populations, disrupted sleep has been linked to greater fatigue and poorer health (Lorton et al., 2006) . Poor sleep quality can be ascertained objectively by overnight polysomnography and subjectively by questionnaires such as the Pittsburgh Sleep Quality Index (PSQI), which measures sleep quality overall and many of its components (Buysse et al., 1989) .
Sleep is commonly disrupted during the course of chronic illnesses (Polo-Kantola et al., 2014) and can also be an important etiological, precipitating, or maintaining factor of disease (Lorton et al., 2006) . Sleep deprivation and loss results in an activation of the immune system, which is evident on a cellular and genomic level (Irwin et al., 2006) . In the context of inflammatory disorders such as ankylosing spondylitis, sleep quality overall and its composite parts (PSQI subscales) are positively correlated with symptom severity and with circulating C-Reactive Protein (CRP) levels (Aydin et al., 2015) .
